Efficacy and Safety on the Use of Bisphosphonates in Paediatrics

NCT04012320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2019-07-09

No results posted yet for this study

Summary

The investigators suppose that the impact of bisphosphonate therapy is beneficial on the bone during the growth period with few adverse events.

Conditions

  • Bone Fragile
  • Bisphosphonate-Associated Osteonecrosis
  • Children
  • Adverse Events

Interventions

OTHER

No intervention, observational study

No intervention, observational study

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04012320 on ClinicalTrials.gov